Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design

Area of Science:

• Neurology
• Medical Diagnostics

Background:

• The Alzheimer's Biomarkers in Daily Practice (ABIDE) project focuses on integrating advanced diagnostic tests for mild cognitive impairment (MCI).
• Key diagnostic modalities include magnetic resonance imaging (MRI), cerebrospinal fluid (CSF) analysis, and amyloid positron emission tomography (PET).

Purpose of the Study:

• To translate existing knowledge on Alzheimer's diagnostic tests into routine clinical practice for MCI.
• To develop practical tools for clinicians to aid in diagnostic test selection and result interpretation.

Main Methods:

• A 3-year project employing a multifaceted design with interconnected quantitative and qualitative substudies.
• Retrospective data analysis for personalized risk estimation in MCI patients.
• Prospective data collection of MRI and CSF from 200 MCI patients and amyloid PET from 500 patients.

Main Results:

• Personalized risk estimates for MCI patients developed from retrospective data.
• Ongoing prospective data collection to optimize the application of MRI, CSF, and amyloid PET in clinical settings.
• Development of strategies for effective patient-clinician communication regarding diagnostic test results.

Conclusions:

• The project will yield practical tools to assist clinicians in choosing appropriate diagnostic tests for MCI.
• Enhanced interpretation and communication of diagnostic test results are anticipated outcomes.
• Improved clinical decision-making for MCI diagnosis and management is the ultimate goal.